Does CANRENOATE Cause Hyperkalaemia? 96 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Hyperkalaemia have been filed in association with CANRENOATE. This represents 21.7% of all adverse event reports for CANRENOATE.
96
Reports of Hyperkalaemia with CANRENOATE
21.7%
of all CANRENOATE reports
7
Deaths
63
Hospitalizations
How Dangerous Is Hyperkalaemia From CANRENOATE?
Of the 96 reports, 7 (7.3%) resulted in death, 63 (65.6%) required hospitalization, and 4 (4.2%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOATE. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOATE Cause?
Acute kidney injury (63)
Toxic epidermal necrolysis (58)
Hyponatraemia (52)
Off label use (45)
Dehydration (39)
Hypotension (39)
Drug hypersensitivity (37)
Dyspnoea (36)
Asthenia (33)
Bradycardia (26)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which CANRENOATE Alternatives Have Lower Hyperkalaemia Risk?
CANRENOATE vs CANRENOIC ACID
CANRENOATE vs CANRENONE
CANRENOATE vs CANTHARIDIN
CANRENOATE vs CAPECITABINE
CANRENOATE vs CAPIVASERTIB